During the 30-day period following Ciba's receipt of the Statement, Ciba and its independent auditors shall be permitted to review the working papers of Diagnostics' independent auditors relating to the Statement. The Statement shall become final and...Investment Agreement • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
or its subsidiaries pursuant to Section 1.04(iv)(3) of the Investment Agreement and consummation of such merger shall satisfy the Company's obligation to repay such amounts at the Closing pursuant to such Section 1.04 (iv)(3). (b) The Company shall...Supplemental Agreement • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
VIA FAX AND FEDERAL EXPRESS September 30, 1999 Gentlemen: This letter confirms the agreement between Chiron Corporation ("Chiron") on behalf of itself and its wholly-owned subsidiary Chiron S.p.A., on the one hand, and Novartis Corporation...Limited Liability Company Agreement • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations
HCV PROBE LICENSE AND OPTION AGREEMENT TABLE OF CONTENTSHCV Probe License and Option Agreement • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations • New York
AMENDMENT WITH RESPECT TO EMPLOYEE STOCK OPTION ARRANGEMENTS, dated January 3, 1995, among CIBA-GEIGY LIMITED, a Swiss corporation ("Ciba"), CIBA-GEIGY CORPORATION, a New York corporation ("CCorp"), CIBA BIOTECH PARTNERSHIP, INC., a Delaware...Employee Stock Option Amendment • November 12th, 1999 • Chiron Corp • Pharmaceutical preparations • Delaware
